LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
SAH
Sonic Automotive, Inc.
SAH has a slight edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SAH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
SAH's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SAH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.7x | $35.57 | -41% |
| Forward | 9.1x | $60.18 | — |
| Current | 9.6x | $60.18 | — |
| Fair | 11x | $66.57 | +11% |
| Expensive | 18x | $110 | +83% |
Historical ranges are pointers, not guarantees.
SAH's PE is in its fair range at 9.6x. If earnings grow as analysts expect, today's price would be 9.1x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SAH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect SAH's earnings to grow, with its revenue and profitability holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
SAH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.62 | +6% |
| Q3 2026 | $6.25 | +69% |
SAH has the edge over LCID in the latest year-over-year earnings comparison.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SAH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SAH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4B | +0.4% |
| Q2 2026 | $3.9B | +7.6% |
| Q1 2026 | $3.7B | +1% |
| Q4 2025 | $3.9B | -0.6% |
SAH's revenue has held roughly level: $4B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 3.4% | +4 points |
| Q1 2026 | 3.6% | -0.4 points |
| Q4 2025 | 3.2% | -0.3 points |
| Q3 2025 | 3.1% | N/A |
| Q2 2025 | -0.6% | N/A |
| Q1 2025 | 4% | N/A |
| Q4 2024 | 3.4% | N/A |
SAH has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SAH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$217.8M | -312% |
| Q1 2026 | -$1.5M | -101% |
| Q4 2025 | $329.4M | -22% |
SAH and LCID do not have enough comparable growth data to identify a winner.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SAH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.6% | -1.9M shares |
| 1 year | -5.9% | -2M shares |
SAH has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $6.3M |
| Q1 2026 | $135.7M |
| Q4 2025 | $126.5M |
| Q3 2025 | — |
| Q2 2025 | $8.8M |
| Q1 2025 | $35.3M |
| Q4 2024 | $61.5M |
SAH spent $269M buying back its own shares over the past year.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SAH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 3.3x | Elevated |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.5x | Moderate |
SAH's net debt is about 2.6 years of its operating earnings (EBITDA), about the same as a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SAH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.2 | Neutral |
| Stochastic | 8.4 | Oversold |
SAH's weekly RSI is 37 (neutral) and its Stochastic is 8 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SAH PE vs Consumer Cyclical Sector
| Metric | SAH | Sector median | Relative |
|---|---|---|---|
| PE | 9.6x | 18x | 47% below |
| PE % | 36 | 47 | 11 pts below |
SAH is trading at 9.6x earnings, a 47% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SAH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.3 | 3.4% below |
| 20 week MA | $75.5 | 20% below |
| 50 week MA | $71.5 | 16% below |
| 100 week MA | $70.8 | 15% below |
| 200 week MA | $62.2 | 3.3% below |
SAH is in a downtrend: it's below all five of its weekly moving averages, and 3.3% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SAH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.6 | $38.2 | +25% |
| 2021 | $38.2 | $48.3 | +27% |
| 2022 | $48.3 | $47.5 | -1.8% |
| 2023 | $47.5 | $56.2 | +18% |
| 2024 | $56.2 | $63.6 | +13% |
| 2025 | $63.6 | $64.3 | +1.1% |
| 2026 YTD | $64.3 | $60.2 | -6.4% |
SAH has the edge over LCID on returns for 2026, with the stronger performance.